Plasma Fractionation Market Size to Record Substantial Reach US$ 40,731.98 million with of 6.3% CAGR by 2028

According to the latest study on Plasma Fractionation Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Application, and End User," the market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028. The report highlights the trends prevailing in the global plasma fractionation market, and drivers and deterrents pertaining to the market growth.

Blood plasma is among the emerging method for treating various chronic diseases. The plasma consists of essential components, such as proteins, albumin, globulins, fibrinogen, clotting factors and inhibitors, and others. It is widely used in blood cancer, COVID19, Atrial fibrillation, leukemia, and others. The plasma is separated from the donated blood by using plasma Fractionation. The regulatory agencies are also providing the required approvals for the use of plasma in treatment processes. For instance, in August 2020, the US Food and Drug Administration (USFDA) issued the emergency use authorization (EUA) for convalescent plasma treatment of COVID-19. In addition to this, in February 2021, the USFDA issued an updated guideline for the plasma EUA for COVID19. Thus active involvement and approval by the regulatory and government are expected to encourage the application of blood plasma.

Get Sample PDF Copy of Plasma Fractionation Market at:
https://www.theinsightpartners.com/sample/TIPRE00003422/?utm_source=OpenPR&utm_medium=10411

List of Companies operating in this report are:
Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, and Octapharma AG

By Product
• Immunoglobulin
o Intravenous Immunoglobulin (IVIG)
o Subcutaneous Immunoglobulin (SCIG)
• Albumin
• Coagulation Factor Concentrates
• Protease Inhibitors
• Other
By Application
• Neurology
• Immunology
• Hematology
• Critical Care
• Pulmonology
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

As stated in the previous driver, the market offers considerable potential for the companies operating the market-related businesses. Due to the positive market growth, the global and regional market players are actively adopting organic and inorganic development strategies. Thus it is expected to attract more significant investments in the market in the forecast period. For instance, below are some of the developments and initiatives adopted by the market players.
In March 2021, Grifols, S.A., among the global leader in plasma-related markets, acquired about 25 US-based plasma centers from Bio Products Laboratory Holdings Limited. It is expected to add about one million liters of plasma for the fractionation processes.

In August 2021, Biotest AG started about the sixth plasma collection centre in the Czech Republic. The company received the operating license for these centres from the national public health authority SUKL. The center is state-of-the-art with about 15 donor beds and has facilities for the donors such as Television(TV), Wi-Fi, and others. The center is operational six days a week for twelve hours a day.

In February 2020, Advent International Corporation a US-based global private equity firm, acquired a majority stake in Bharat Serums and Vaccines. This investment is expected to strengthen and expand Bharat Serums' offerings in domestic and global markets.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003422/?utm_source=OpenPR&utm_medium=10411

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Plasma Fractionation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Plasma Fractionation market.

Essential points covered in Plasma Fractionation market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of Plasma Fractionation market?
3 What are the key market trends impacting Plasma Fractionation market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Plasma Fractionation market?
6 Which are the leading companies contributing to Plasma Fractionation market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Plasma Fractionation market in 2028?

Furthermore, the market is segmented based on type, application, and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Order a Copy of Plasma Fractionation Market Share, Strategies and Forecasts 2021-2027 Research Report at:
https://www.theinsightpartners.com/buy/TIPRE00003422/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.